Skip to main content
. 2016 Jul 29;6(7):e454. doi: 10.1038/bcj.2016.65

Figure 1.

Figure 1

Risk of progression in SMM patients, stratified by the number of risk factors (eMP, eHb and BMPC ⩾20%) at diagnosis. P<0.001.